Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies
- 1 April 2014
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 46 (9) , 1715-1728
Abstract
Several epidemiologic studies were performed to clarify the protective effect of regular aspirin use on prostate cancer risk; however, the results remain controversial. Therefore, we conducted this meta-analysis to assess the association between regular aspirin use and risk of prostate cancer.Keywords
This publication has 40 references indexed in Scilit:
- Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO StudyBritish Journal of Cancer, 2012
- Aspirin and urologic cancer risk: an updateNature Reviews Urology, 2012
- Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A Population-Based Nested Case-Control StudyPLOS ONE, 2011
- Long‐term aspirin use and the risk of total, high‐grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988–2006International Journal of Cancer, 2010
- Nonsteroidal Anti-Inflammatory Drugs and Prostate Cancer Risk in the VITamins And Lifestyle (VITAL) CohortCancer Epidemiology, Biomarkers & Prevention, 2010
- Use of Aspirin and Other Nonsteroidal Antiinflammatory Medications in Relation to Prostate Cancer RiskAmerican Journal of Epidemiology, 2010
- Aspirin, salicylates, and cancerThe Lancet, 2009
- A Large Cohort Study of Long-Term Daily Use of Adult-Strength Aspirin and Cancer IncidenceJNCI: Journal of the National Cancer Institute, 2007
- A Large Cohort Study of Aspirin and Other Nonsteroidal Anti-inflammatory Drugs and Prostate Cancer IncidenceJNCI: Journal of the National Cancer Institute, 2005
- Effect of Nonsteroidal Anti-Inflammatory Agents and Finasteride on Prostate Cancer RiskJournal of Urology, 2002